Intensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancer.
about
Thoracic Vertebral Body Irradiation Contributes to Acute Hematologic Toxicity During Chemoradiation Therapy for Non-Small Cell Lung Cancer.Radiobiological evaluation of simultaneously dose-escalated versus non-escalated intensity-modulated radiation therapy for patients with upper thoracic esophageal cancer.High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.Different definitions of esophagus influence esophageal toxicity prediction for esophageal cancer patients administered simultaneous integrated boost versus standard-dose radiation therapyRadiation dose does not influence anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation and transhiatal esophagectomy.Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity.An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning.Intrafractional dose variation and beam configuration in carbon ion radiotherapy for esophageal cancer.High-dose versus conventional-dose irradiation in cisplatin-based definitive concurrent chemoradiotherapy for esophageal cancer: a systematic review and pooled analysis.Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.Recent advances in intensity modulated radiotherapy and proton therapy for esophageal cancer.The SCOPE of definitive chemoradiotherapy in locally advanced esophageal cancer: what direction for the future?High dose-rate endoluminal brachytherapy for primary and recurrent esophageal cancer : Experience from a large single-center cohort.Dosimetric predictors of acute haematological toxicity in oesophageal cancer patients treated with neoadjuvant chemoradiotherapyThe effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation.Dosimetric and clinical outcomes after volumetric modulated arc therapy for carcinoma of the thoracic esophagus.Visibility of fiducial markers used for image-guided radiation therapy on optical coherence tomography for registration with CT: An esophageal phantom study.Bortezomib sensitizes esophageal squamous cancer cells to radiotherapy by suppressing the expression of HIF-1α and apoptosis proteins.Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis.Dosimetric comparison between modulated arc therapy and static intensity modulated radiotherapy in thoracic esophageal cancer: a single institutional experience.Efficacy of virtual block objects in reducing the lung dose in helical tomotherapy planning for cervical oesophageal cancer: a planning study.Surgery combined with radio-chemotherapy for esophageal mucoepidermoid carcinoma: A case report.Feasibility of using optical coherence tomography to detect radiation-induced fibrosis and residual cancer extent after neoadjuvant chemo-radiation therapy: an ex vivo study
P2860
Q33428648-72706E4A-2CE4-4DE9-AA02-90974284A88DQ33597464-21F49641-C2A8-48BB-9C50-383AF8F1548BQ33633596-4B61FAE6-757E-4FDE-8684-BAAED2331C47Q33669384-B58B67ED-2B09-4774-9CBD-98DFD4FBEEAEQ35206602-5911AC07-1D1C-440B-A73F-541947E19C29Q36348600-68323B1D-BCCD-4852-8321-ADEB334F7A12Q36818873-0113050C-35A4-444B-87CE-D6EDEE3B7901Q37414605-DC7513BF-23F8-4BF3-BE2F-5F8E865007B0Q38559388-45BC5267-B148-4D5A-B8CA-6896FDE9B166Q38623448-B0A06B0F-1256-4D31-BA6F-A15D50FEBDA1Q38683954-4C0486F3-052F-4537-8B1A-2508494285FBQ38854234-11486A74-3B19-408F-9ABC-D29A9CE75946Q39721434-4EFB9441-F739-41F7-AE15-F614FA1E1BA0Q41635449-FBBD372E-DD2C-4F68-B537-6AAA15BC0BB0Q42628995-087AAEF4-724C-4F41-A18D-F8B579190DFCQ43379701-B0CAF85E-85F5-48B0-887F-74927EC5DDF1Q47576384-86B3C046-9FE4-4236-80B8-694479717DD8Q52874910-94660BBC-4822-4775-A98F-A119ACF960CEQ55035451-C2F5EC05-9EC6-4D13-AB8B-3698273331A4Q55323942-29335714-CF63-4A0C-BB33-B445E471CFE7Q55341693-7D5E9FCE-E489-47B2-8F6D-65D56C93FEC0Q55437120-69D77185-D219-419C-8415-127CE309F862Q58779621-54817C1C-E4BE-448A-BDAB-50956E1C88BB
P2860
Intensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Intensity modulated radiothera ...... ly advanced esophageal cancer.
@ast
Intensity modulated radiothera ...... ly advanced esophageal cancer.
@en
type
label
Intensity modulated radiothera ...... ly advanced esophageal cancer.
@ast
Intensity modulated radiothera ...... ly advanced esophageal cancer.
@en
prefLabel
Intensity modulated radiothera ...... ly advanced esophageal cancer.
@ast
Intensity modulated radiothera ...... ly advanced esophageal cancer.
@en
P2093
P2860
P356
P1433
P1476
Intensity modulated radiothera ...... ly advanced esophageal cancer.
@en
P2093
Carmen Timke
Falk Roeder
Felix Zwicker
Ladan Saleh-Ebrahimi
Nils H Nicolay
Peter E Huber
Tam Nguyen
Tilman Bostel
Vasilis Askoxylakis
P2860
P2888
P356
10.1186/1748-717X-9-191
P50
P577
2014-08-29T00:00:00Z
P6179
1024085195